J. Jang‐Ho

4.5k total citations · 2 hit papers
29 papers, 3.6k citations indexed

About

J. Jang‐Ho is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, J. Jang‐Ho has authored 29 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in J. Jang‐Ho's work include Genetic Neurodegenerative Diseases (20 papers), Mitochondrial Function and Pathology (12 papers) and Neuroscience and Neuropharmacology Research (8 papers). J. Jang‐Ho is often cited by papers focused on Genetic Neurodegenerative Diseases (20 papers), Mitochondrial Function and Pathology (12 papers) and Neuroscience and Neuropharmacology Research (8 papers). J. Jang‐Ho collaborates with scholars based in United States, United Kingdom and Switzerland. J. Jang‐Ho's co-authors include Ghazaleh Sadri‐Vakili, John B. Penney, Mingwei Li, Robert M. Friedlander, Victor Ona, Anne B. Young, Laurie Farrell, Robert J. Ferrante, Gillian P. Bates and Christoph M. Kosinski and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

J. Jang‐Ho

29 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

2000 869 citations Minghua Chen, Victor Ona et al. Nature Medicine profile →
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

1999 504 citations Victor Ona, Mingwei Li et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Jang‐Ho United States	20	2.6k	2.4k	952	382	243	29	3.6k
Amber L. Southwell Canada	31	2.0k 0.8×	2.3k 0.9×	687 0.7×	196 0.5×	200 0.8×	48	3.2k
Jean‐Paul Vonsattel United States	13	3.3k 1.3×	2.7k 1.1×	1.9k 2.0×	449 1.2×	180 0.7×	20	4.4k
Lesley Jones United Kingdom	36	1.8k 0.7×	2.3k 0.9×	698 0.7×	181 0.5×	290 1.2×	79	3.3k
Huu Phuc Nguyen Germany	36	2.3k 0.9×	2.3k 0.9×	1.0k 1.1×	222 0.6×	206 0.8×	155	3.9k
Esther Pérez‐Navarro Spain	33	2.0k 0.8×	1.6k 0.6×	606 0.6×	216 0.6×	175 0.7×	90	2.8k
Simonetta Sipione Canada	30	2.3k 0.9×	3.0k 1.2×	775 0.8×	240 0.6×	273 1.1×	51	4.2k
Cristina Richichi Italy	26	1.6k 0.6×	1.6k 0.6×	332 0.3×	562 1.5×	266 1.1×	38	3.8k
Svetlana Vidensky United States	16	1.3k 0.5×	1.5k 0.6×	947 1.0×	581 1.5×	114 0.5×	18	3.2k
Vikram G. Shakkottai United States	29	2.0k 0.8×	2.2k 0.9×	665 0.7×	232 0.6×	240 1.0×	68	3.1k
Kirupa Sathasivam United Kingdom	22	4.8k 1.9×	4.8k 1.9×	1.7k 1.8×	232 0.6×	372 1.5×	32	5.9k

Countries citing papers authored by J. Jang‐Ho

Since Specialization

Citations

This map shows the geographic impact of J. Jang‐Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jang‐Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jang‐Ho more than expected).

Fields of papers citing papers by J. Jang‐Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jang‐Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jang‐Ho. The network helps show where J. Jang‐Ho may publish in the future.

Co-authorship network of co-authors of J. Jang‐Ho

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jang‐Ho. A scholar is included among the top collaborators of J. Jang‐Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jang‐Ho. J. Jang‐Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McFarland, Karen N., Sudeshna Das, Ting Sun, et al.. (2012). Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease. PLoS ONE. 7(7). e41423–e41423. 66 indexed citations

Schmidt, Heath D., Gavin R. Sangrey, Rachel L. Schassburger, et al.. (2011). Increased brain‐derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I‐containing promoters. Journal of Neurochemistry. 120(2). 202–209. 84 indexed citations

McFarland, Karen N. & J. Jang‐Ho. (2011). Molecular biology of Huntington's disease. Handbook of clinical neurology. 100. 25–81. 16 indexed citations

Anderson, Sharon M., Katie R. Famous, Ghazaleh Sadri‐Vakili, et al.. (2008). CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nature Neuroscience. 11(3). 344–353. 237 indexed citations

Overland, Ryan, et al.. (2008). Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation. Journal of Neuroscience. 28(15). 3947–3957. 50 indexed citations

Jang‐Ho, J.. (2007). Finding diamonds in the rubble. Experimental Neurology. 205(1). 1–4. 1 indexed citations

Sadri‐Vakili, Ghazaleh, Caroline Benn, Ryan Overland, et al.. (2007). Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Human Molecular Genetics. 16(11). 1293–1306. 170 indexed citations

Sadri‐Vakili, Ghazaleh & J. Jang‐Ho. (2006). Mechanisms of Disease: histone modifications in Huntington's disease. Nature Clinical Practice Neurology. 2(6). 330–338. 111 indexed citations

Qiu, Zhihua, Bhupinder Singh, Raman Chopra, et al.. (2006). Sp1 Is Up-regulated in Cellular and Transgenic Models of Huntington Disease, and Its Reduction Is Neuroprotective. Journal of Biological Chemistry. 281(24). 16672–16680. 100 indexed citations

10.

Jang‐Ho, J., Karen L. Furie, Jonathan Kay, et al.. (2006). Case 39-2006. New England Journal of Medicine. 355(25). 2678–2689. 16 indexed citations

11.

Chen‐Plotkin, Alice, et al.. (2004). Chromatin Immunoprecipitation Technique for Study of Transcriptional Dysregulation in Intact Mouse Brain. Humana Press eBooks. 277. 261–276. 15 indexed citations

12.

Benn, Caroline, Laurie Farrell, & J. Jang‐Ho. (2004). Neurotransmitter Receptor Analysis in Transgenic Mouse Models. Humana Press eBooks. 277. 231–260. 12 indexed citations

13.

Leegwater‐Kim, Julie & J. Jang‐Ho. (2004). The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration. PubMed. 1(1). 128–138. 51 indexed citations

14.

Yohrling, George J., Laurie Farrell, Anthony N. Hollenberg, & J. Jang‐Ho. (2003). Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation. Molecular and Cellular Neuroscience. 23(1). 28–38. 32 indexed citations

15.

Yohrling, George J., et al.. (2002). Inhibition of tryptophan hydroxylase activity and decreased 5‐HT_1A receptor binding in a mouse model of Huntington's disease. Journal of Neurochemistry. 82(6). 1416–1423. 38 indexed citations

16.

Chen, Minghua, Victor Ona, Mingwei Li, et al.. (2000). Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Medicine. 6(7). 797–801. 869 indexed citations breakdown →

17.

Ona, Victor, Mingwei Li, Jean Paul Vonsattel, et al.. (1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature. 399(6733). 263–267. 504 indexed citations breakdown →

18.

Friedlander, Robert M., Victor Ona, Mingwei Li, et al.. (1999). Intraventricular Administration of a Caspase Inhibitor Delays Disease Progression and Mortality in a Mouse Model of Huntington's Disease. Neurosurgery. 45(3). 718–718. 2 indexed citations

19.

Nielsen, Elsebet Ø., Jørgen Drejer, J. Jang‐Ho, Anne B. Young, & Tage Honoré. (1990). Autoradiographic Characterization and Localization of Quisqualate Binding Sites in Rat Brain Using the Antagonist [³H]6‐Cyano‐7‐Nitroquinoxaline‐2,3‐Dione: Comparison with (R,S)‐[³H]α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding Sites. Journal of Neurochemistry. 54(2). 686–695. 95 indexed citations

20.

Makowiec, Richard L., Roger L. Albin, J. Jang‐Ho, A. Byron Young, & Sid Gilman. (1990). Two types of quisqualate receptors are decreased in human olivopontocerebellar atrophy cerebellar cortex. Brain Research. 523(2). 309–312. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact